Pearl River Capital, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Pearl River Capital, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,859,606
-22.0%
68,519
-11.6%
0.29%
-24.0%
Q2 2023$2,382,627
+63.8%
77,509
+110.6%
0.38%
+55.5%
Q4 2022$1,454,178
+17.2%
36,796
+19.1%
0.25%
+6.9%
Q3 2022$1,241,000
+38.4%
30,896
+34.2%
0.23%
-6.1%
Q1 2022$897,000
+10.9%
23,024
+13.4%
0.25%
+12.3%
Q4 2021$809,000
+137.2%
20,300
+115.5%
0.22%
+135.5%
Q3 2021$341,000
-58.4%
9,422
-52.8%
0.09%
-58.8%
Q2 2021$819,00019,9690.23%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders